Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury
Merrie Mosedale, Paul B. Watkins
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 12, pp. 6436-6461
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice
Marina Villanueva-Paz, L. Ortega Morán, Nuria López‐Alcántara, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 390-390
Open Access | Times Cited: 115
Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies
Bryan H. Norman
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 20, pp. 11397-11419
Closed Access | Times Cited: 86
Approaches to mitigate the risk of serious adverse reactions in covalent drug design
Thomas A. Baillie
Expert Opinion on Drug Discovery (2020) Vol. 16, Iss. 3, pp. 275-287
Closed Access | Times Cited: 35
The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
Samantha Christine Sernoskie, Alison Jee, Jack Uetrecht
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 861-896
Open Access | Times Cited: 30
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB‐506 from Phase 1 studies in healthy subjects and those with hepatitis B
Man‐Fung Yuen, Elina Berliba, Wattana Sukeepaisarnjaroen, et al.
Hepatology Communications (2022) Vol. 6, Iss. 12, pp. 3457-3472
Open Access | Times Cited: 21
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate
P. G. Humphreys, Stephen J. Atkinson, Paul Bamborough, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2262-2287
Open Access | Times Cited: 20
Alterations in zonal distribution and plasma membrane localization of hepatocyte bile acid transporters in patients with NAFLD
William A. Murphy, Anna Mae Diehl, Matthew Shane Loop, et al.
Hepatology Communications (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 4
Prediction of cytochrome P450-mediated bioactivation using machine learning models and in vitro validation
Xin-Man Hu, Yan-Yao Hou, Xin-Ru Teng, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 5, pp. 1457-1467
Closed Access | Times Cited: 4
Metabolomics analysis of anaphylactoid reactions induced by Xueshuantong injection in normal and immunocompromised mice
Xiaoqian Guo, Chi Zhang, Yingyu Li, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
In-Depth Understanding of the Structure-Based Reactive Metabolite Formation of Organic Functional Groups
Chunyong He, Yuchang Mao, Hong Wan
Drug Metabolism Reviews (2025), pp. 1-43
Closed Access
Blood toxicogenomics reveals potential biomarkers for management of idiosyncratic drug-induced liver injury
Rachel J. Church, Benedict Anchang, Brian D. Bennett, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Modifications of the Triaminoaryl Metabophore of Flupirtine and Retigabine Aimed at Avoiding Quinone Diimine Formation
Konrad W. Wurm, Frieda‐Marie Bartz, Lukas Schulig, et al.
ACS Omega (2022) Vol. 7, Iss. 9, pp. 7989-8012
Open Access | Times Cited: 18
Preclinical evaluation of chemically reactive metabolites and mitigation of bioactivation in drug discovery
Chunyong He, Yuchang Mao, Hong Wan
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103621-103621
Closed Access | Times Cited: 8
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease
David A. Candito, Vladimir Simov, Anmol Gulati, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16801-16817
Closed Access | Times Cited: 13
Human-relevant mechanisms and risk factors for TAK-875-Induced liver injury identified via a gene pathway-based approach in Collaborative Cross mice
Merrie Mosedale, Yanwei Cai, J. Scott Eaddy, et al.
Toxicology (2021) Vol. 461, pp. 152902-152902
Open Access | Times Cited: 17
Combining DELs and machine learning for toxicology prediction
Vincent Blay, Xiaoyu Li, Jacob Gerlach, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 11, pp. 103351-103351
Open Access | Times Cited: 12
Involvement of Extracellular Vesicles in the Proinflammatory Response to Clozapine: Implications for Clozapine-Induced Agranulocytosis
Samantha Christine Sernoskie, Éric Bonneil, Pierre Thibault, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 388, Iss. 3, pp. 827-845
Open Access | Times Cited: 2
DILIsym: Quantitative systems toxicology impacting drug development
Paul B. Watkins
Current Opinion in Toxicology (2020) Vol. 23-24, pp. 67-73
Closed Access | Times Cited: 17
Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity
Takeshi Susukida, Saki Kuwahara, Binbin Song, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 11
Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition
James J. Beaudoin, Kyunghee Yang, Jeffry Adiwidjaja, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 4
Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosis
Anindit Chhibber, Alexandre H. Watanabe, H. R. D. Jacobs, et al.
Journal of Cystic Fibrosis (2024) Vol. 23, Iss. 5, pp. 1010-1019
Closed Access | Times Cited: 1
An Engineered Protein-Based Building Block (Albumin Methacryloyl) for Fabrication of a 3D In Vitro Cryogel Model
X. Niu, Mian Lin, Bae Hoon Lee
Gels (2022) Vol. 8, Iss. 7, pp. 404-404
Open Access | Times Cited: 7
Machine Learning for Predicting Risk of Drug-Induced Autoimmune Diseases by Structural Alerts and Daily Dose
Yue Wu, Jieqiang Zhu, Peter P. Fu, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 13, pp. 7139-7139
Open Access | Times Cited: 9
A novel pipeline of 2-(benzenesulfonamide)-N-(4-hydroxyphenyl) acetamide analgesics that lack hepatotoxicity and retain antipyresis
Hernan A. Bazan, Surjyadipta Bhattacharjee, Carolina Burgos, et al.
European Journal of Medicinal Chemistry (2020) Vol. 202, pp. 112600-112600
Open Access | Times Cited: 7
Biochemical and Molecular Basis of Toxicity
Lois D. Lehman‐McKeeman, Laura E. Armstrong
Elsevier eBooks (2021), pp. 15-49
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top